Regeneron Pharmaceuticals, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ALNY
|
Alnylam Pharmaceuticals, Inc. | $275.07 | $19.33 B | -57.65 | 2100 | $1.83 B |
 APLS
|
Apellis Pharmaceuticals, Inc. | $28.80 | $4.90 B | -11.77 | 702 | $396.59 M |
 ARWR
|
Arrowhead Pharmaceuticals, Inc. | $19.35 | $2.97 B | -5.65 | 525 | $240.74 M |
 BGNE
|
BeiGene, Ltd. | $224.77 | $17.07 B | -20.76 | 10000 | $2.46 B |
 BMRN
|
BioMarin Pharmaceutical Inc. | $70.27 | $15.32 B | 76.12 | 3401 | $2.42 B |
 CRSP
|
CRISPR Therapeutics AG | $46.97 | $4.91 B | -21.43 | 407 | $370.00 M |
 ICPT
|
Intercept Pharmaceuticals, Inc. | $19.00 | $794.69 M | -17.43 | 341 | $285.71 M |
 IMGN
|
ImmunoGen, Inc. | $31.24 | $8.73 B | -111.55 | 277 | $108.78 M |
 INCY
|
Incyte Corporation | $66.09 | $13.30 B | 17.93 | 2524 | $3.70 B |
 IONS
|
Ionis Pharmaceuticals, Inc. | $40.06 | $5.69 B | -14.59 | 927 | $787.65 M |
 KRYS
|
Krystal Biotech, Inc. | $181.83 | $4.70 B | 75.42 | 229 | $50.70 M |
 MDGL
|
Madrigal Pharmaceuticals, Inc. | $212.23 | $5.21 B | -10.55 | 376 | $0 |
 NTLA
|
Intellia Therapeutics, Inc. | $20.54 | $2.19 B | -4.23 | 526 | $36.28 M |
 NVO
|
Novo Nordisk A/S | $119.06 | $606.41 B | 49.27 | 69260 | $232.26 B |
 PTCT
|
PTC Therapeutics, Inc. | $37.09 | $2.80 B | -4.75 | 988 | $937.82 M |
 RARE
|
Ultragenyx Pharmaceutical Inc. | $55.58 | $3.44 B | -5.21 | 1276 | $434.25 M |
 RETA
|
Reata Pharmaceuticals, Inc. | $172.36 | $6.57 B | -66.29 | 321 | $2.22 M |
 RXDX
|
Prometheus Biosciences, Inc. | $199.92 | $9.56 B | -56.47 | 97 | $6.81 M |
 SRPT
|
Sarepta Therapeutics, Inc. | $124.94 | $11.66 B | 286.79 | 1314 | $1.24 B |
 UTHR
|
United Therapeutics Corporation | $358.14 | $12.20 B | 13.02 | 1168 | $2.33 B |